Name: Avalo Therapeutics, Inc. (AVTX) Balance Sheet
Creator: FinSpry

Avalo Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Avalo Therapeutics, Inc. (AVTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	134.55	7.40	13.17	54.59	18.92	11.26
Cash & Short-Term Investments	134.55	7.40	13.17	54.59	18.92	11.26
Accounts Receivable	0.61	0.14	1.92	1.06	4.39	5.24
Inventory	0.00	0.00	0.02	0.04	0.00	0.02
Other Current Assets	3.73	0.84	1.29	2.37	2.66	0.50
Total Current Assets	138.89	8.38	16.42	61.85	26.01	17.72
Non-Current Assets
Property, Plant & Equipment (Net)	1.21	-1.97	2.41	2.70	1.61	0.72
Goodwill	10.50	10.50	14.41	14.41	14.41	0.00
Intangible Assets	0.00	0.00	0.00	0.04	1.59	0.00
Other Non-Current Assets	0.13	0.13	0.13	1.23	0.15	0.10
Total Non-Current Assets	11.84	8.67	16.95	18.37	17.75	18.38
Total Assets	150.73	20.99	33.37	80.21	43.76	36.11
Current Liabilities
Accounts Payable	0.28	6.62	2.88	3.37	2.57	8.27
Short-Term Debt	0.57	0.00	5.93	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	5.93	0.00	0.00	0.00
Accrued Liabilities	5.22	3.06	9.00	11.34	8.86	0.00
Deferred Revenue	0.00	0.00	0.09	0.00	0.00	0.00
Other Current Liabilities	6.11	0.58	0.48	0.01	3.36	3.89
Total Current Liabilities	6.96	6.62	22.11	19.89	15.23	12.16
Non-Current Liabilities
Long-Term Debt	0.00	0.00	13.49	32.83	0.00	0.00
Deferred Tax Liabilities	0.27	0.16	0.14	0.11	0.09	0.00
Other Non-Current Liabilities	10.47	1.37	3.71	4.30	2.84	1.11
Total Non-Current Liabilities	10.74	7.07	22.17	37.24	1.97	2.95
Total Liabilities	17.70	13.69	44.28	57.13	19.19	15.11
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.01	0.08	0.00
Retained Earnings	-370.26	-335.13	-303.82	-262.17	-177.79	-114.29
Additional Paid-in Capital	503.29	342.44	292.91	285.24	202.28	135.24
Shares Outstanding	10.47	0.80	0.04	0.04	0.00	0.00
Total Stockholders' Equity	133.03	7.30	-10.92	23.08	24.56	21.00
Total Liabilities & Equity	150.73	20.99	33.37	80.21	43.76	36.11